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Abstract
Background: Alcohol abuse has dramatic effects on the health of the elderly. Recent studies indicate that ethanol
increases immune activity in younger animals and that some of these proinflammatory molecules alter alcohol
consumption and addiction. However, the effects of alcohol on immune activation in aged animals have not been
thoroughly investigated.
Findings: We compared the effects of ethanol on chemokine and cytokine expression in the hippocampus,
cerebellum, and cerebral cortex of aged C57BL/6 mice. Mice were treated via gavage with 6 g/kg ethanol for 10
days and tissue was harvested 1 day post-treatment. Ethanol selectively increased mRNA levels of the chemokine
(C-C motif) ligand 2/monocyte chemotactic protein-1 in the hippocampus and cerebellum, but not in the cortex of
aged mice relative to control animals. In this paradigm, ethanol did not affect mRNA levels of the cytokines IL-6 or
TNF-α in any of these brain regions in aged animals.
Conclusions: Collectively, these data indicate a region-specific susceptibility to ethanol regulation of
neuroinflammatory and addiction-related molecules in aged mice. These studies could have important implications
concerning alcohol-induced neuropathology and alcohol addiction in the elderly.
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Findings
Introduction
Alcohol abuse has significant effects on the health of the
elderly population. The rates of alcoholism are high in
this population. In addition, alcohol consumption in the
elderly population is associated with increased motor
impairment and increased withdrawal symptoms [1]. As-
trocytes and microglia normally maintain homeostasis in
the central nervous system (CNS) by collectively
maintaining energy balance, removing toxic molecules,
providing growth factors which help maintain the health
of neurons, and by removing cellular debris (reviewed in
[2,3]). However, when chronically activated, these glial
cells can produce molecules that can be toxic to CNS
cells [3]. Interestingly, a variety of studies indicate that
the morphology of glia changes with aging, and these
cells exhibit a more activated phenotype [4,5]. Aging glia
have been demonstrated to express increased levels of
inflammatory molecules including chemokines and cyto-
kines, which are consistent with activated glial pheno-
types. Further, glial activation is associated with a variety
of age-related neuropathologies [4,6,7]. A series of stud-
ies indicated that alcohol increased immune activity in
the CNS, which is believed to contribute to impaired
neurological function and neurodegeneration associated
with excess alcohol consumption. These studies indi-
cated that alcohol increased the expression of
proinflammatory cytokines and chemokines as well as
cyclooxygenase-2, and nitric oxide in the CNS [8-12].
More recently, a paradigm shift regarding the role of
alcohol-induced CNS inflammation occurred when it
was determined that pro-inflammatory molecules in-
cluding cytokines and chemokines modulate alcohol
consumption, suggesting that these molecules are im-
portant mediators of alcohol addiction [13,14].
Little is known concerning the effects of ethanol on
immune activity in the aged CNS. Two studies evaluated
long-term ethanol exposure in aged rat cerebellum. In
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one study, ethanol was observed to have no effect on the
density of glial fibrillary acidic protein-positive cerebellar
Bergmann glial fibers or OX-42 expression by microglia
relative to vehicle-treated animals [15]. In another study,
chronic alcohol exposure decreased the density of
Bergmann glia [16]. The reasons for the differences in
experimental observations in these two studies are not
clear, but likely involve differences in experimental de-
sign. More recently, the expression of the chemokine
(C-C motif ) ligand 2 (CCL2) was shown to be elevated
in the CNS of the brains of human chronic alcoholics
with a mean age of 61 to 64 years [17], which may sug-
gest that CCL2 plays an important role in alcohol
addiction.
The current study was designed to evaluate the re-
gional effects of ethanol on immune response in the
aged brain. Our study demonstrates that ethanol in-




Animal treatments were performed under protocols ap-
proved by the Institutional Animal Care and Use Com-
mittee at the University of Arkansas for Medical
Sciences. Mice (C57BL6) were originally obtained from
Jackson Laboratories (Bar Harbor, ME, USA) and were
bred in-house in a Division of Laboratory Animal Medi-
cine approved facility. Aged mice (364 to 457 days old)
were treated with ethanol (15% w/v diluted from 95% v/
v ethanol) or water (vehicle control) by gavage for 10
days. Ethanol was administered in two daily doses sepa-
rated by 7 hours at a dose of 6 g/kg/day. Tissue was
harvested 1 day after the final ethanol treatment from
animals anesthetized with isoflurane.
Blood ethanol concentrations
In a separate set of animals, blood ethanol concentra-
tions (BECs) were evaluated using an AM1 Alcohol
Analyzer as described by the manufacturer (Analox,
Huntington Beach, CA, USA). In these studies, BECs
were determined in mice (n = 14) 1 hour following the
second dose of ethanol.
RNA isolation and cDNA synthesis
Following anesthesia, blood was removed from the brain
vasculature by briefly perfusing animals transcardially
with phosphate buffered saline containing heparin.
Brains were harvested, the hippocampus, cerebellum,
and cerebral cortex were dissected, and the tissue imme-
diately frozen in liquid nitrogen. The tissue was homog-
enized using a BBX24B Bullet Blender Blue homogenizer
in a solution containing 0.5 mm RNAse-free beads (Next
Advance, Averill Park, NY, USA). RNA was isolated
from the homogenized tissue using a RNeasy Lipid Tis-
sue Mini Kit (Qiagen, Valencia, CA, USA). The concen-
tration and integrity of the resulting RNA was evaluated
using an RNA 6000 Nano kit and associated Agilent
2100 bioanalyser (Agilent Technologies, Santa Clara,
CA, USA). Contaminating DNA was removed from
RNA samples with DNAseI (Invitrogen, Grand Island,
NY, USA) and were determined to have RIN values > 8.
cDNA was prepared using an iScript™ cDNA synthesis
kit as described by the manufacturer (Bio-Rad, Hercules,
CA, USA).
Real-time quantitative polymerase chain reaction
The relative quantity of CCL2, IL-6, and TNF-α mRNAs
was determined by real time polymerase chain reaction
(rtPCR) using a CFX96 Real-time PCR Detection System
(Bio-Rad). TaqMan primers were utilized in the rtPCR
analysis and were synthesized by Applied Biosystems
(Foster City, CA, USA). PCR reactions (20 μl) contained
SsoFast™ probe supermix (Bio-Rad) and were performed
in duplicate. Data were expressed as the mean ΔCt rela-
tive to β-actin. The fold expression variance of ethanol
versus vehicle groups was generated by calculating the
ΔΔCt. Student’s t-test was used to analyze variance be-
tween groups.
Results and discussion
Ethanol is known to induce an innate immune response
in the CNS, which may contribute to ethanol-induced
neurodegeneration. In addition, ethanol abuse is com-
mon and has significant health consequences in the eld-
erly population. However, the effects of ethanol on
innate immune responses in aged animals have not been
investigated. In the current studies, we demonstrate that
ethanol increased the expression of the chemokine
CCL2 in the hippocampus (Figure 1A) and cerebellum
(Figure 1B), but not the cerebral cortex (Figure 1C) of
aged mice. Ethanol did not increase the expression of
IL-6 and TNF-α in any of these brain regions in aged
mice. In a separate set of animals, BECs were deter-
mined to be 307 ± 17.43 mg/dl.
It is well established that ethanol alters innate immune
activity in the developing and adult CNS (reviewed in
[13,18,19]), but ethanol effects on innate immune activ-
ity are relatively unknown in the aged CNS. Our studies
demonstrate for the first time that ethanol increases the
expression of CCL2 in the hippocampus and cerebellum
of aged mice. CCL2 expression has been demonstrated
to be increased in the CNS of human alcoholics [17].
The expression of this chemokine was also increased in
the whole brain of adult mice treated with ethanol [20].
Studies with CCL2 knockout mice also demonstrated
that CCL2 increases alcohol consumption [21]. Collect-
ively, our studies demonstrating increased CCL2
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expression in the CNS of ethanol-treated aged mice sug-
gest that ethanol induced neuroinflammation may con-
tribute to neuropathology and alcohol addiction in the
elderly. The current studies utilized a relatively acute
model of alcohol treatment in aged animals previously
naïve to alcohol exposure. Future studies are needed to
evaluate the effects of chronic alcohol exposure in ani-
mals treated with alcohol during different life stages on
the aged CNS. These studies may better approximate al-
cohol drinking behavior in elderly humans. Future stud-
ies will also need to directly compare the effects of
alcohol on innate immune activity in the CNS at distinct
life stages. Our unpublished studies indicate that alcohol
increases the innate immune response in adult more
than adolescent CNS, while the effects of alcohol on the
innate immune response in the aged CNS appears to be
intermediate between the adolescent and adult CNS.
It should be noted that ethanol effects on pro-
inflammatory molecules were modest in the aged CNS
in the current studies. For example, we did not see etha-
nol induction of IL-6 or TNF-α in any of the brain re-
gions investigated. This is distinct from previous studies
demonstrating induction of these cytokines in non-aged
animals (reviewed in [13]). In fact, CCL2 was the only
pro-inflammatory molecule that we observed to be in-
creased by ethanol treatment of aged animals. CCL2 has
been demonstrated to be expressed by neurons as well
as glia. Neurons are also believed to express CCL2 re-
ceptors and respond to this chemokine. In addition, this
chemokine has been demonstrated to alter synaptic plas-
ticity in the hippocampus and is believed to suppress the
toxic effects of alcohol in the CNS [22]. Collectively, this
suggests that alcohol induction of CCL2 in the aged
brain may represent a non-immune adaptive response to
alcohol. It is possible that alcohol-induced innate im-
mune activity in distinct regions of the hippocampus,
cerebellum, and cortex were missed due to dilution ef-
fects in our analysis of these entire brain regions. There
is precedence in the literature that alcohol selectively
Figure 1 Effect of ethanol on chemokine (C-C motif) ligand 2,
interleukin-6, and tumor necrosis factor-α expression in aged
mouse hippocampus, cerebellum, and cerebral cortex. Animals
were given 6.0 g/kg/day ethanol split into two doses administered 7
hours apart. Ethanol was administered for 10 days and mice were
sacrificed 24 hours after the final dose of ethanol. Water was
administered to vehicle mice. Hippocampus (A), cerebellum (B), and
cerebral cortex (C) were isolated, RNA prepared, cDNA synthesized
and mRNA levels were determined by real-time quantitative
polymerase chain reaction. Results are expressed as fold changes
relative to vehicle-treated mice, and all values are normalized against
β-actin. Values are mean ± standard error of the mean from 9
vehicle and 12 ethanol-treated aged mice. Duplicate polymerase
chain reactions were performed on each sample. *P <0.05, **P <0.01,
versus vehicle-treated mice. CCL2, chemokine (C-C motif) ligand 2;
IL, interleukin; TNF, tumor necrosis factor.
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damages specific regions of the cortex, for example [23].
Additional studies are warranted to evaluate the effects
of alcohol on innate immune responses in selective
regions of the hippocampus, cerebellum, and cortex.
A primary purpose of the current studies was to deter-
mine if ethanol altered the expression of proinfla-
mmatory molecules in a region-specific manner in the
CNS of elderly mice. To this end, we evaluated the ef-
fects of ethanol on CCL2, IL-6, and TNF-α expression in
the hippocampus, cerebellum, and cerebral cortex. These
brain regions are susceptible to ethanol-induced neuro-
pathology. They also control neurocognitive and motor
deficits resulting from ethanol exposure, as well as alco-
hol addiction. Furthermore, the structure and function
of these regions is altered by ethanol exposure [24]. The
hippocampus and other limbic structures play critical
roles in learning, memory, and alcohol addiction [25].
Ethanol alters balance and motor coordination mediated
by the cerebellum. The cerebellum and cerebral cortex
mediate sedative and hypnotic effects of ethanol, which
impact alcohol intoxication. Our studies demonstrate
that ethanol increases CCL2 expression in the hippo-
campus and cerebellum. This suggests that changes in
CCL2 expression may play a role in ethanol damage in
key brain regions that control an array of behavioral
dysfunctions associated with alcohol abuse.
The current studies demonstrated that ethanol in-
duced CCL2 selectively in the hippocampus and cerebel-
lum but not the cerebral cortex of aged mice. Ethanol
did not increase IL-6 or TNF-α expression in any of
these regions. These studies have important implications
concerning ethanol-induced neuropathology and alcohol
addiction in the elderly.
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